Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 14Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 7Melanoma 6Pancreatic Neoplasms 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplastic Cells, Circulating 4Hematologic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leukemia 3Glioblastoma 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Liver Diseases 2Kidney Neoplasms 2Glioma 2Fibrosis 2

Interventions

Ultrasonography 2tislelizumab 1Narrow Band Imaging 1Mammography 1Immune Checkpoint Inhibitors 1High-Energy Shock Waves 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hypersensitivity × Blood Specimen Collection × Clear all
NCT05181202 2022-01-06

Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown
20 enrolled
Breast

Breast Neoplasms, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡